Kentaro Tanaka Selected Research

Interleukin-13

6/2012	IL-6 induced by double-stranded RNA augments allergic inflammation via suppression of Foxp3+ T-cell/IL-10 axis.
6/2009	Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kentaro Tanaka Research Topics

Disease

45	Neoplasms (Cancer) 03/2024 - 03/2011
42	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 10/2010
12	Lung Neoplasms (Lung Cancer) 03/2024 - 04/2011
10	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024 - 04/2011
9	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2013
5	Disease Progression 12/2023 - 01/2020
5	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 05/2021
5	Infections 10/2023 - 03/2011
5	Asthma (Bronchial Asthma) 01/2023 - 05/2006
4	Adenocarcinoma of Lung 10/2023 - 01/2018
4	Pleural Effusion (Pleural Effusions) 12/2019 - 07/2018
3	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2024 - 01/2020
3	Thrombosis (Thrombus) 04/2024 - 12/2015
3	Atherosclerotic Plaque (Atheroma) 11/2022 - 01/2015
3	Inflammation (Inflammations) 11/2022 - 06/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 12/2015
3	Pain (Aches) 01/2022 - 05/2016
3	Anorexia 01/2022 - 10/2019
3	Type 2 Diabetes Mellitus (MODY) 06/2016 - 11/2013
2	Headache (Headaches) 05/2024 - 01/2018
2	Myocardial Infarction 04/2024 - 12/2015
2	Chronic Renal Insufficiency 04/2022 - 01/2022
2	Neuralgia (Stump Neuralgia) 01/2022 - 09/2021
2	Edema (Dropsy) 01/2022 - 01/2019
2	Body Weight (Weight, Body) 01/2022 - 01/2022
2	Hypovolemia 01/2022 - 01/2020
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2020 - 01/2020
2	Sarcoidosis (Schaumann Disease) 01/2020 - 09/2005
2	Arthralgia (Joint Pain) 03/2019 - 01/2018
2	Anemia 01/2019 - 01/2018
2	Iron Deficiencies 01/2018 - 01/2018
2	Carcinoma (Carcinomatosis) 10/2017 - 05/2016
2	Melanoma (Melanoma, Malignant) 08/2016 - 01/2013
2	Hyperuricemia 12/2014 - 06/2011
2	Eosinophilia 06/2012 - 05/2006
1	Posterior Leukoencephalopathy Syndrome 05/2024
1	Sleep Initiation and Maintenance Disorders (Insomnia) 05/2024

Drug/Important Bio-Agent (IBA)

17	Immune Checkpoint InhibitorsIBA 10/2023 - 07/2018
14	ErbB Receptors (EGF Receptor)IBA 12/2023 - 06/2013
11	osimertinibIBA 03/2024 - 01/2021
11	Tyrosine Kinase InhibitorsIBA 03/2024 - 06/2013
9	LigandsIBA 10/2023 - 11/2017
8	PlatinumIBA 12/2023 - 12/2018
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2013
6	Pemetrexed (MTA)FDA Link 12/2023 - 01/2020
5	CytokinesIBA 03/2023 - 06/2008
5	NivolumabIBA 12/2022 - 08/2016
4	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2018
4	pembrolizumabIBA 08/2023 - 10/2017
4	Monoclonal AntibodiesIBA 01/2023 - 06/2012
3	atezolizumabIBA 03/2023 - 01/2020
3	CalreticulinIBA 03/2023 - 01/2021
3	Transcription Factors (Transcription Factor)IBA 12/2021 - 01/2020
3	Carboplatin (JM8)FDA LinkGeneric 12/2021 - 01/2021
3	Uric Acid (Urate)IBA 01/2021 - 06/2011
3	AfatinibIBA 11/2020 - 09/2017
3	NeuropeptidesIBA 10/2019 - 05/2006
3	Hemoglobins (Hemoglobin)IBA 01/2018 - 06/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 12/2021
2	alectinibIBA 01/2024 - 01/2021
2	CreatinineIBA 12/2023 - 12/2019
2	Peptides (Polypeptides)IBA 11/2023 - 01/2020
2	Bevacizumab (Avastin)FDA Link 03/2023 - 01/2020
2	benralizumabIBA 01/2023 - 01/2023
2	LipidsIBA 11/2022 - 01/2015
2	omega-Chloroacetophenone (Mace)IBA 06/2022 - 12/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 01/2022
2	Vasopressins (Vasopressin)IBA 01/2022 - 05/2014
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2022 - 01/2020
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 01/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 07/2018
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 05/2021
2	Arginine Vasopressin (Argipressin)IBA 01/2022 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 12/2021 - 12/2018
2	AlbuminsIBA 05/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 07/2020 - 05/2016
2	Immune Checkpoint ProteinsIBA 01/2020 - 12/2019
2	AntibodiesIBA 12/2019 - 01/2019
2	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 01/2018
2	delta proteinIBA 01/2019 - 01/2018
2	rovalpituzumab tesirineIBA 01/2019 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2017 - 12/2014
2	AllergensIBA 06/2012 - 05/2006
2	Interleukin-13IBA 06/2012 - 06/2009
1	Calcineurin InhibitorsIBA 05/2024
1	Prednisolone (Predate)FDA LinkGeneric 05/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 05/2024
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2024
1	lemborexantIBA 05/2024

Therapy/Procedure

25	Therapeutics 03/2023 - 09/2005
14	Drug Therapy (Chemotherapy) 12/2023 - 04/2011
5	Renal Dialysis (Hemodialysis) 01/2021 - 09/2005
4	Stents 04/2024 - 12/2015
4	Radiotherapy 12/2023 - 03/2011
4	Immunotherapy 01/2023 - 01/2021
3	Ligation 09/2021 - 09/2017
3	Glycemic Control 06/2016 - 11/2013
2	Chemoradiotherapy 03/2024 - 05/2016
2	Free Tissue Flaps 12/2021 - 09/2013
2	Lymph Node Excision (Lymph Node Dissection) 08/2016 - 01/2013